Publications
Information about journal articles, updated at 01-12-2024, from platform CIÊNCIAVITAE.
Adenosine A2A Receptors Shut Down Adenosine A1 Receptor-Mediated Presynaptic Inhibition to Promote Implementation of Hippocampal Long-Term Potentiation
Cátia R. Lopes; Francisco Q. Gonçalves; Simão Olaio; Angelo R. Tomé; Rodrigo A. Cunha; João Pedro Lopes, Biomolecules. 2023. https://doi.org/10.3390/biom13040715 . 10.3390/biom13040715 . Biomolecules
Downregulation of Sirtuin 1 Does Not Account for the Impaired Long-Term Potentiation in the Prefrontal Cortex of Female APPswe/PS1dE9 Mice Modelling Alzheimer’s Disease
Cátia R. Lopes; Joana S. Silva; Joana Santos; Matilde S. Rodrigues; Daniela Madeira; Andreia Oliveira; Ana Moreira-de-Sá; et al, International Journal of Molecular Sciences. 2023. https://www.mdpi.com/1422-0067/24/8/6968 . 10.3390/ijms24086968 . International Journal of Molecular Sciences
Adenosine A2A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aß1–42 to Model Early Alzheimer’s Disease
Cátia R. Lopes; António C. Silva; Henrique B. Silva; Paula M. Canas; Paula Agostinho; Rodrigo A. Cunha; João Pedro Lopes, Biomolecules. 2023. https://doi.org/10.3390/biom13081173 . 10.3390/biom13081173 . Biomolecules
Effects of Chronic Caffeine Consumption on Synaptic Function, Metabolism and Adenosine Modulation in Different Brain Areas
Cátia R. Lopes; Andreia Oliveira; Ingride Gaspar; Matilde S. Rodrigues; Joana Santos; Eszter Szabó; Henrique B. Silva; et al, Biomolecules. 2023. https://www.mdpi.com/2218-273X/13/1/106 . 10.3390/biom13010106 . Biomolecules
CD73-Mediated Formation of Extracellular Adenosine Is Responsible for Adenosine A2A Receptor-Mediated Control of Fear Memory and Amygdala Plasticity
Ana Patrícia Simões; Francisco Q. Gonçalves; Daniel Rial; Samira G. Ferreira; João Pedro Lopes; Paula M. Canas; Cunha, R.A., International Journal of Molecular Sciences. 12826 - 12826. 21. 23. 2022. http://dx.doi.org/10.3390/ijms232112826 . 10.3390/ijms232112826 . International Journal of Molecular Sciences
Impact of blunting astrocyte activity on hippocampal synaptic plasticity in a mouse model of early Alzheimer's disease based on amyloid-ß peptide exposure
Lopes, C.R.; Amaral, I.M.; Pereira, M.F.; Lopes, J.P.; Madeira, D.; Canas, P.M.; Cunha, R.A.; Agostinho, P., Journal of Neurochemistry. 556 - 567. 5. 160. 2022. http://www.scopus.com/inward/record.url?eid=2-s2.0-85124559190&partnerID=MN8TOARS . 10.1111/jnc.15575 . Journal of Neurochemistry
Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage.
Valada P; Alçada-Morais S; Cunha RA; Lopes JP, International journal of molecular sciences. 2022. http://europepmc.org/abstract/med/36142422 . 10.3390/ijms231810510 . International journal of molecular sciences
The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors.
Valada P; Hinz S; Vielmuth C; Lopes CR; Cunha RA; Müller CE; Lopes JP, Purinergic signalling. 2022. http://europepmc.org/abstract/med/36156760 . 10.1007/s11302-022-09899-7 . Purinergic signalling
l-a-aminoadipate causes astrocyte pathology with negative impact on mouse hippocampal synaptic plasticity and memory
Pereira, Marlene F.; Amaral, Inês M.; Lopes, Cátia; Leitão, Catarina; Madeira, Daniela; Lopes, João P.; Gonçalves, Francisco Q.; et al, The FASEB Journal. 8. 35. 2021. http://dx.doi.org/10.1096/fj.202100336r . 10.1096/fj.202100336r . The FASEB Journal
Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices
Fernandes, M.Y.D.; Dobrachinski, F.; Silva, H.B.; Lopes, J.P.; Gonçalves, F.Q.; Soares, F.A.A.; Porciúncula, L.O.; et al, Scientific Reports. 1. 11. 2021. http://www.scopus.com/inward/record.url?eid=2-s2.0-85106020393&partnerID=MN8TOARS . 10.1038/s41598-021-89964-0 . Scientific Reports
Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am-/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade
Ana Moreira-de-Sá; Francisco Q. Gonçalves; João P. Lopes; Henrique B. Silva; Ângelo R. Tomé; Rodrigo A. Cunha; Paula M. Canas, Molecular Neurobiology. 2021. https://doi.org/10.1007/s12035-020-02275-9 . 10.1007/s12035-020-02275-9 . Molecular Neurobiology
Adenosine A2A receptors format long-term depression and memory strategies in a mouse model of Angelman syndrome.
Lopes, João, Neurobiology of disease. 2020. https://doi.org/10.1016/j.nbd.2020.105137 . 10.1016/j.nbd.2020.105137 . Neurobiology of disease
The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors
João P. Lopes; Anna Pliássova; Rodrigo A. Cunha, Biochemical Pharmacology. 313 - 321. 166. 2019. https://doi.org/10.1016/j.bcp.2019.06.008 . 10.1016/j.bcp.2019.06.008 . Biochemical Pharmacology
Synaptic and memory dysfunction in a ß-amyloid model of early Alzheimer's disease depends on increased formation of ATP-derived extracellular adenosine
Gonçalves, Francisco Q.; Lopes, João P.; Silva, Henrique B.; Lemos, Cristina; Silva, António C.; Gonçalves, Nélio; Tomé, Ângelo R.; et al, Neurobiology of Disease. 132. 2019. http://dx.doi.org/10.1016/j.nbd.2019.104570 . 10.1016/j.nbd.2019.104570 . Neurobiology of Disease
What is the extracellular calcium concentration within brain synapses?
João Pedro Lopes; Rodrigo A. Cunha, Journal of Neurochemistry. 435 - 437. 4. 149. 2019. https://doi.org/10.1111/jnc.14696 . 10.1111/jnc.14696 . Journal of Neurochemistry
Chronic adenosine A2A receptor blockade induces locomotor sensitization and potentiates striatal LTD IN GPR37-deficient mice
Morató, X.; Gonçalves, F.Q.; Lopes, J.P.; Jauregui, O.; Soler, C.; Fernández-Dueñas, V.; Cunha, R.A.; Ciruela, F., Journal of Neurochemistry. 796 - 809. 6. 148. 2019. http://www.scopus.com/inward/record.url?eid=2-s2.0-85060713664&partnerID=MN8TOARS . 10.1111/jnc.14653 . Journal of Neurochemistry
Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease
Silva, António C.; Lemos, Cristina; Gonçalves, Francisco Q.; Pliássova, Anna V.; Machado, Nuno J.; Silva, Henrique B.; Canas, Paula M.; et al, Neurobiology of Disease. 72 - 81. 117. 2018. http://dx.doi.org/10.1016/j.nbd.2018.05.024 . 10.1016/j.nbd.2018.05.024 . Neurobiology of Disease
The Association of Amyloid-ß Protein Precursor With a- and ß-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer's Disease.
Pliássova A; Lopes JP; Lemos C; Oliveira CR; Cunha RA; Agostinho P, 2016. http://europepmc.org/abstract/med/26497029 . 10.1007/s12035-015-9491-9 .
The role of parkinson's disease-associated receptor GPR37 in the hippocampus: Functional interplay with the adenosinergic system
Lopes, J.P.; Morató, X.; Souza, C.; Pinhal, C.; Machado, N.J.; Canas, P.M.; Silva, H.B.; et al, Journal of Neurochemistry. 2015. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928177504&partnerID=MN8TOARS . 10.1111/jnc.13109 . Journal of Neurochemistry
Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
Capurro, V.; Busquet, P.; Lopes, J.P.; Bertorelli, R.; Tarozzo, G.; Bolognesi, M.L.; Piomelli, D.; Reggiani, A.; Cavalli, A., PLoS ONE. 2. 8. 2013. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874153672&partnerID=MN8TOARS . 10.1371/journal.pone.0056870 . PLoS ONE
Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
Lopes, J.P.; Tarozzo, G.; Reggiani, A.; Piomelli, D.; Cavalli, A., Brain and Behavior. 67 - 74. 2. 3. 2013. http://www.scopus.com/inward/record.url?eid=2-s2.0-84893466236&partnerID=MN8TOARS . 10.1002/brb3.118 . Brain and Behavior
Cdk5: Multitasking between physiological and pathological conditions
Lopes, J.P.; Agostinho, P., Progress in Neurobiology. 49 - 63. 1. 94. 2011. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955109480&partnerID=MN8TOARS . 10.1016/j.pneurobio.2011.03.006 . Progress in Neurobiology
Neurodegeneration in an Aß-induced model of Alzheimer's disease: The role of Cdk5
Lopes, J.P.; Oliveira, C.R.; Agostinho, P., Aging Cell. 64 - 77. 1. 9. 2010. http://www.scopus.com/inward/record.url?eid=2-s2.0-76249103674&partnerID=MN8TOARS . 10.1111/j.1474-9726.2009.00536.x . Aging Cell
Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-ß and prion peptides
Lopes, J.P.; Oliveira, C.R.; Agostinho, P., Cell Cycle. 97 - 104. 1. 8. 2009. http://www.scopus.com/inward/record.url?eid=2-s2.0-60749123603&partnerID=MN8TOARS . Cell Cycle
Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-ß and tau pathology
Lopes, J.P.; Blurton-Jones, M.; Yamasaki, T.R.; Agostinho, P.; Laferla, F.M., Journal of Alzheimer's Disease. 541 - 549. 3. 16. 2009. http://www.scopus.com/inward/record.url?eid=2-s2.0-65549145514&partnerID=MN8TOARS . 10.3233/JAD-2009-0993 . Journal of Alzheimer's Disease
Cell cycle re-entry in Alzheimer's disease: A major neuropathological characteristic?
Lopes, J.P.; Oliveira, C.R.; Agostinho, P., Current Alzheimer Research. 205 - 212. 3. 6. 2009. http://www.scopus.com/inward/record.url?eid=2-s2.0-67149106183&partnerID=MN8TOARS . 10.2174/156720509788486590 . Current Alzheimer Research
Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-ß and prion peptides
Lopes, João P.; Oliveira, Catarina R.; Agostinho, Paula, Cell Cycle. 97 - 104. 1. 8. 2009. http://dx.doi.org/10.4161/cc.8.1.7506 . 10.4161/cc.8.1.7506 . Cell Cycle
Overactivation of calcineurin induced by amyloid-beta and prion proteins
Agostinho, P.; Lopes, J.P.; Velez, Z.; Oliveira, C.R., Neurochemistry International. 1226 - 1233. 6. 52. 2008. http://www.scopus.com/inward/record.url?eid=2-s2.0-40949104298&partnerID=MN8TOARS . 10.1016/j.neuint.2008.01.005 . Neurochemistry International
Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-beta and prion peptides: Implications for Alzheimer's disease and prion-related encephalopathies
Lopes, J.P.; Oliveira, C.R.; Agostinho, P., Cellular and Molecular Neurobiology. 943 - 957. 7. 27. 2007. http://www.scopus.com/inward/record.url?eid=2-s2.0-37549015597&partnerID=MN8TOARS . 10.1007/s10571-007-9224-3 . Cellular and Molecular Neurobiology
Perfil de expressão génica por PCR em tempo real em doentes VIH negativos com tuberculose multirresistente
Santos, P.; Cunha, A.; Lopes, J.P.; Domingos, A.; Regateiro, F.; Segorbe-Luís, A., Revista Portuguesa de Pneumologia. 5. 9. 2003. http://dx.doi.org/10.1016/s0873-2159(15)30711-x . 10.1016/s0873-2159(15)30711-x . Revista Portuguesa de Pneumologia
5 30 out of 30 Publications
All projects
Information of exclusive responsibility of the researcher 01-12-2024 , from platform CIÊNCIAVITAE.
2023/07/31 - 2029/07/30
Harnessing the potential of VNUT modulation against memory dysfunction in Alzheimer's Disease
2022.05689.CEECIND/CP1714/CT0015
Principal investigator
Universidade de Coimbra
Funders: Fundação para a Ciência e a Tecnologia
2021/01/01 - 2025/12/31
Center for Innovative Biomedicine and Biotechnology - Associate Laboratory
LA/P/0058/2020
Universidade de Coimbra; Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra; Universidade de Coimbra Centro de Neurociências e Biologia Celular
Funders: Fundação para a Ciência e a Tecnologia
2019/01/01 - 2019/12/31
CNC. IBILI
UID/NEU/04539/2019
Universidade de Coimbra Centro de Neurociências e Biologia Celular; Universidade de Coimbra; Universidade de Coimbra Instituto de Ciências Nucleares Aplicadas à Saúde; Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra
Funders: Fundação para a Ciência e a Tecnologia
2019/02/05 - 2023/07/30
Impact of purinergic neuromodulation in neurodegenerative brain pathologies
DL 57/2016/CP1448/CT0001
Principal investigator
Universidade de Coimbra Centro de Neurociências e Biologia Celular
Funders: Fundação para a Ciência e a Tecnologia
2018/01/01 - 2019/06/30
Manipulation of A2A receptors to control symptoms of Angelman syndrome
---
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Fundação Amélia de Melo
2018 -
Adenosine A2A receptors as a new opportunity to manage and detail the neurobiology of emotional distress
Fundacion LaCaixa
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Fundação para a Ciência e a Tecnologia; Fundación La Caixa
2018/07 - 2021/06
Recetores A2A da adenosina como desencadeadores de disfunção mnemónica na doença de Alzheimer: mecanismos e possibilidade terapêutica
Provided by PTCRIS: PTDC/MED-NEU/31274/2017
Funders: Fundação para a Ciência e a Tecnologia
2018/05/01 - 2020/06/06
Strategies for healthy aging
CENTRO-01-0246-FEDER-000010
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
2017 -
Study of caffeine derivatives in the inhibition of Alzheimer's disease and as a base for novel drugs
-
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Fundação para a Ciência e a Tecnologia
2017 -
Study of caffeine derivatives in the inhibition of Alzheimer's disease and as a base for novel drugs
-
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Fundação para a Ciência e a Tecnologia
2016/05 - 2019/07
Papel dos astrócitos no controlo da memória- foco nos recetores adenosina A2A
Provided by PTCRIS: PTDC/NEU-NMC/4154/2014
Funders: Fundação para a Ciência e a Tecnologia
2016/10 - 2017/09
Adenosine A2A Receptor Antagonism Affords Integrated Benefits for Neurological Symptoms of Neurofibromatosis Type I
W81XWH-18-1-0532
Post-doc Fellow
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Congressionally Directed Medical Research Programs
2015/01/01 - 2017/06/30
The up-regulation of hippocampal adenosine A2A receptors is necessary and sufficient to trigger memory dysfunction in Alzheimer's disease
Mantero-Bellard Award
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Santa Casa da Misericórdia de Lisboa
2013/01 - 2019/02
Tinkering with adenosine metabolism to manipulate adenosine neuromdulation and bolster neuroprotectin in brain disorders
Provided by PTCRIS: SFRH/BPD/85404/2012
Funders: Fundação para a Ciência e a Tecnologia
2012/05 - 2014/08
Papel fisio-patológico da ecto-5`-nucleotidase - um novo alvo para neuroprotecção
122005PRJ
Funders: Fundação para a Ciência e a Tecnologia
2011/08 - 2013/12
Localization and metabolism of APP controlling synaptic degeneration in animal models of Alzheimer's disease
Provided by PTCRIS: 114810
Post-doc Fellow
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Fundação para a Ciência e a Tecnologia
2008 -
Causas e consequências da reactivação do ciclo celular nos neurónios: implicações na doença de Alzheimer e nas encefalopatias por priões
GAPI 01/08
PhD Student Fellow
Universidade de Coimbra Faculdade de Medicina
2007 -
Neuroinflamação associada à doenca de Alzheimer
GAPI 04/07
PhD Student Fellow
Universidade de Coimbra Faculdade de Medicina
2006 -
Degeneração neuronal associada à doenca de Alzheimer e às encefalopatias causadas por priões
GAI 05/06
PhD Student Fellow
Universidade de Coimbra Faculdade de Medicina
2005 -
Disfunção colinérgica na doença de Alzheimer: avaliação da capacidade neuroprotectora de compostos com acção antioxidante e inibidora das colinesterases
GAI 14/05
PhD Student Fellow
Universidade de Coimbra Faculdade de Medicina
2005/01 - 2008/12
NEURODEGENERATION IN ALZHEIMER´S DISEASE AND PRION RELATED ENCEPHALOPATHIES: THE ROLE OF CYCLIN-DEPENDENT KINASE 5 AND CELL CYCLE REGULATORS
Provided by PTCRIS: SFRH/BD/16381/2004
Funders: Fundação para a Ciência e a Tecnologia
2004 -
O efeito de novos inibidores das colinesterases na neurotoxicidade do peptídeo beta amilóide. Potenciais agentes terapêuticos na doença de Alzheimer
GAI 05/04
Master Student Fellow
Universidade de Coimbra Faculdade de Medicina
2003/09/01 - 2004/12/31
A comparative study of the neurotoxic mechanisms of prion and amyloid-beta peptides. Potential neuroprotective strategies
POCTI/36101/NSE/1999
Master Student Fellow
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
Funders: Fundação para a Ciência e a Tecnologia
5 23 out of 23 projects
We use cookies to improve your visit to our website.